Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 2OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 22Burkitt Lymphoma 17Central Nervous System Neoplasms 15Neuroblastoma 13Lymphoma, Large B-Cell, Diffuse 13Sarcoma 11Lymphoma, Follicular 11Hodgkin Disease 10Brain Neoplasms 10Medulloblastoma 9Rhabdomyosarcoma 8Wilms Tumor 7Leukemia, Biphenotypic, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large-Cell, Anaplastic 6Oligodendroglioma 5Lymphoma, Mantle-Cell 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Multiple Myeloma 4Malignant mesenchymal tumor 4Dendritic Cell Sarcoma, Interdigitating 4Astrocytoma 4Waldenstrom Macroglobulinemia 3Sarcoma, Ewing 3Rhabdoid Tumor 3Lymphoma, Large-Cell, Immunoblastic 3Ganglioneuroblastoma 3

Interventions

Temozolomide 4Watchful Waiting 2Vincristine 2Filgrastim 2Etoposide 2Cyclophosphamide 2Cisplatin 2veliparib 1omburtamab I-131 1lonafarnib 1imetelstat 1Triiodothyronine 1Radiotherapy, Conformal 1Radiotherapy 1Potassium Iodide 1Platinum 1Observation 1Mesna 1Irinotecan 1Histamine Antagonists 1Granulocyte Colony-Stimulating Factor 1GRN163L peptide 1Dexamethasone 1Chemotherapy, Adjuvant 1Carboplatin 1Bevacizumab 1Antipyretics 1Antiemetics 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Ependymoma × Vincristine × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

NCT00003309 2023-06-22

Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
33 enrolled
CNS

Ependymoma, Medulloblastoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡